Serum cotinine predicts bronchial obstruction regardless of self-reported smoking history

Abstract

Background: We studied ability of serum cotinine and detailed history of smoking to predict bronchial obstruction. Methods: The baseline study was done during the Mini-Finland Health Survey in 1980 and the follow-up study during the Health 2000 Survey in 2000 for a total of 662 persons free from bronchial obstruction at baseline. Spirometric values of the ratio of forced expiratory volume in one second to forced vital capacity (FEV%) <80% were defined as moderate and <70% as severe bronchial obstruction at follow-up. Cotinine was determined from frozen serum samples collected at baseline. Results: For those who reported at baseline not to smoke currently but whose serum cotinine (≥100 μg/l) indicated active smoking, the age- and sex-adjusted odds ratio of bronchial obstruction at follow-up was 2.55 (95% CI 1.26—5.19) compared with the ‘‘true non-smokers’’ (<100 μg/l). Among current smokers, after adjustment for age, sex, pack years, daily consumption of cigarettes, and inhalation of smoke, the odds ratio of moderate and severe bronchial obstruction was 1.61 (95% CI 1.12— 2.32) and 1.97 (95% CI 1.10—3.54) per an increment of one standard deviation (367 μg/l) in serum cotinine. The predictive value of all the interview measures of past or current smoking was clearly lower. Conclusions: Serum cotinine concentration is a useful predictor for development of obstruction. Smoking history alone may be insufficient in risk factor studies focusing on smoking-related diseases.

Keywords

Chronic obstructive pulmonary disease cigarette smoking cotinine smoking and health spirometry

Get full access to this article

View all access options for this article.

References

Fletcher C. , Peto R. , Tinker C. , Speizer S. The natural history of chronic bronchitis and emphysema. Oxford, UK: Oxford University Press; 1976. pp. 122-257.

Fletcher C. , Peto R. The natural history of chronic airflow obstruction . BMJ 1977;1(6077):1645-8.

Troisi RJ , Speizer FE , Rosner B. , Trichopoulos D. , Willett WC Cigarette smoking and incidence of chronic bronchitis and asthma in women . Chest 1995;108(6):1557-61.

Senior RM and Anthonisen NR Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1998;157(4Pt2):139-47.

Siafakas NM , Vermeire P. , Pride NB , Paoletti P. , Gibson J. , Howard P. , et al. ERS Consensus statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8(8):1398-420.

Pauwels RA , Buist AS , Calverley PMA , Jenkins CR , Hurd SS Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163(5):1256-76.

Rebagliato M. Validation of self reported smoking. J Epidemiol Community Health 2002;56(3):163-4.

Korpilahde T. , Heliovaara M. , Knekt P. , Marniemi J. , Aromaa A. , Aho K. Smoking history and serum cotinine and thiocyanate concentrations as determinants of rheumatoid factor in non-rheumatoid subjects . Rheumatology ( Oxford) 2004;43(11):1424-8.

Benowitz NL , Jacob III P. , Denaro C. , Jenkins R. Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 1991 ;49(3):270-7.

10.

Pérez-Stable EJ , Benowitz NL , Marín G. Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med Mar 1995 ;24(2):171-9.

11.

Vartiainen E. , Seppälä T. , Lilsunde P. , Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study . J Epidemiol Community Health 2002;56(3):167-70.

12.

Benowitz NL Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996;18(2):188-204.

13.

Emmons KM , Abrams DB , Marshall R. , Marcus BH , Kane M. , Novotny TE , et al. An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposure. Prev Med 1994;23(1):35-9.

14.

Heistaro S (ed.) Menetelmäraportti. Terveys 2000 -tutkimuksen toteutus, aineisto ja menetelmät [in Finnish with English abstract]. Helsinki: KTL, 2005. B6.

15.

Crapo RA Pulmonary-function testing. N Engl J Med 1994 ;331(1):25-30.